Who are Non ionic contrast media comparator's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Imeron, E-Z-Hd, Visipaque 270, Ultravist 370, Ioxitol, Optiray 320.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/non-ionic-contrast-media-comparator.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Non ionic contrast media comparator — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Non ionic contrast media comparator (Non ionic contrast media comparator) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Radiographic contrast agent. Area: Diagnostic Imaging.

marketed Radiographic contrast agent Diagnostic Imaging Small molecule Live · refreshed every 30 min

Target snapshot

Non ionic contrast media comparator (Non ionic contrast media comparator) — Bracco Diagnostics, Inc. Non-ionic contrast media enhance the visibility of blood vessels and organs during radiographic imaging by increasing radiodensity without causing significant osmotic effects.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
Non ionic contrast media comparator TARGET	Non ionic contrast media comparator	Bracco Diagnostics, Inc	marketed	Radiographic contrast agent
Imeron	IOMEPROL		marketed	Radiographic Contrast Agent [EPC]	2024-01-01
E-Z-Hd	BARIUM SULFATE		marketed	Radiographic Contrast Agent [EPC]	2016-01-01
Visipaque 270	IODIXANOL	GE HealthCare	marketed	Radiographic Contrast Agent	1996-01-01
Ultravist 370	IOPROMIDE	Bayer	marketed	Radiographic Contrast Agent	1995-01-01
Ioxitol	IOXILAN	Guerbet	marketed	Radiographic Contrast Agent	1995-01-01
Optiray 320	IOVERSOL	Liebel-Flarsheim	marketed	Radiographic Contrast Agent [EPC]	1988-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Radiographic contrast agent class)

Bracco Diagnostics, Inc · 1 drug in this class
University of Leipzig · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Non ionic contrast media comparator — Competitive Intelligence Brief. https://druglandscape.com/ci/non-ionic-contrast-media-comparator. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing